EDEN PRAIRIE, MINN. — November 19, 2025 — Leads & Copy —
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) announced its participation in two upcoming medical industry conferences.
The American Epilepsy Society (AES) 2025 Annual Meeting in Atlanta, GA, will take place December 5th – December 9th. The AES Annual Meeting brings together healthcare providers, scientists, advocates, industry representatives, and other professionals focused on improved outcomes for individuals with epilepsy. More information can be found here: AES Annual Meeting Registration
The CNS Drug Delivery Summit in Boston, MA, is scheduled for December 9th – 11th. This summit brings together over 100 industry experts, including neuroscientists, chemists, device engineers, conjugation scientists, DMPK experts, and delivery specialists, for collaboration and networking. Participants will explore strategies to tackle challenges in accessing the brain. Additional details are available here: CNS Drug Delivery Conference
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) focuses on developing and commercializing minimally invasive, hi-definition solutions for EEG recording, monitoring, ablation, drug delivery, and stimulation for patients with epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain from failed back surgeries, as well as other neurological disorders. The company also explores applications for conditions such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence.
MZ Group – MZ North America
NMTC@mzgroup.us
Source: NeuroOne Medical Technologies Corporation
